Home -> Law Blog Directory -> Patent Law Blogs -> IPBiz
(866) 635-2689 for Personal Injury or (866) 635-9402 for Criminal Defense
Find a Local Lawyer
Divorce (866) 635-6190
Personal Injury (866) 635-2689
Criminal Defense (866) 635-9402
Patent Law
: IPBizTafas briefs, and confusion among the law professor set, again
By Lawrence B. Ebert, Esq.
In support of Tafas:
AIPLA File Attachment: aipla.PDF (1020 KB)
BIO File Attachment: bio.pdf (240 KB)
Cantor Fitzgerald File Attachment: cantorfitz.pdf (376 KB) (rules improperly shift burden of proof)
ELAN File Attachment: elan.pdf (7683 KB)
Intellectual Ventures, et al. File Attachment: intven.pdf (936 KB)
IPO File Attachment: ipo.pdf (1306 KB)
Lelkes, esq. File Attachment: lelkesprose.pdf (321 KB) (discussing how the rules would violate the PCT)
Licensing Professionals File Attachment: licensingcos.pdf (1400 KB)
Monsanto File Attachment: monsanto.pdf (243 KB) (provides a specific example of how the final rules will impact the company?s rights)
NYIPLA File Attachment: nyipla.pdf (3313 KB)
PhRMA File Attachment: phrma.pdf (263 KB) (discussing the financial impact of the rule change)
SonicWall File Attachment: sonicwall.pdf (104 KB)
William Mitchell File Attachment: williammitchell.pdf (1145 KB)
In support of the PTO:
Law Professors File Attachment: lemley.pdf (510 KB)
PubPat File Attachment: pubpat.pdf (149 KB)
Lemley cited "Ending Abuse..." once in the brief, on page 22, for, of all things, "submarine patenting," a procedure which no longer exists. Out of touch, out of touch...
***In passing
Yochai Benkler, formerly at Yale, is now at Harvard.
Full post as published by IPBiz on October 15, 2008 (boomark / email).
Class Action Filed Over Incontinence Briefs
Arizona Health Care Faces Federal Class Action over Incontinence Briefs

Briefs Flying In Patent Office Appeal of Continuation Rules
Dr. Tafas Files Brief in New Rules Appeal
Tafas v. Dudas: USPTO Exceded Its Rulemaking Authority with Proposed Limitations on Continuations
Tafas v. Dudas: The Continuation Wars
No April Fool's Joke -- Tafas and GSK Win on Summary Judgment








